US Senator Calls Out Big Pharma Over Improper Inhaler Patents
AstraZeneca, Boehringer Ingelheim, GSK And Teva Urged To Remove Patents From Orange Book
US Senator Baldwin’s letters to four inhaler manufacturers come after the FTC challenged their patents last year, but the companies rejected patent amendment claims.
